Delayed conception or sildenafil prevents endothelial dysfunction in pregnant rats after renal ischemia-reperfusion
Abstract
Nearly half of patients with acute kidney injury (AKI) are female, and the incidence is rising. Pregnant women with a history of AKI experience disproportionately high adverse pregnancy outcomes even after clinical measures suggest renal recovery. Many adverse outcomes of pregnancy are mediated by endothelial dysfunction, but the vascular consequences post-AKI in females remain to be identified. Furthermore, whether endothelial dysfunction is a mediator of poor pregnancy outcomes induced by a history of AKI is unexplored. We tested the hypothesis that renal ischemia-reperfusion (IR) results in sustained endothelial dysfunction in females in extrarenal, peripheral vascular tissues, and this contributes to adverse pregnancy outcomes post-IR as a model of AKI in rats. Female Sprague Dawley rats underwent 45-min bilateral renal IR or sham surgery. Rats were randomized to sham, mated 30 days or 6 mo post-IR, or placed on control chow or chow supplemented with sildenafil (phosphodiesterase 5 inhibitor, 12.5 mg/day) starting 15 days post-IR and throughout gestation. Mesenteric arteries isolated from rats that became pregnant 30 days post-IR exhibited lower acetylcholine-mediated vasorelaxation compared with sham controls. In contrast, rats allowed to recover for 6 mo post-IR did not exhibit endothelial dysfunction in pregnancy; however, vascular contractility was increased. Sildenafil treatment in 30-day post-IR dams also restored endothelial function, lowered uterine artery…
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.